Crowdonomics
Adia Nutrition, Inc.

Reg A+ · Equity · Apr 2024

ClosedReg A+Equity
via the platform · last checked Aug 16, 2026
Raised
$0 / $937.5K max
0% of ceiling
Investors
—
—
Estimated pre-money
$1.2M
—

Financials disclosed in this offering

FY2023 · hover for source
$0
−$750
FY2023
RevenueNet income
Metric
FY2023 unaudited
Income statement
Revenue
$0
Cost of goods sold
$0
Net income
-$750
Balance sheet
Cash
$500
Accounts receivable
$0
Total assets
$500
Long-term debt
$0
Total liabilities
$1,250
Other
Headcount
2

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

4 amendments
  1. Jun 18, 2024
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  2. Jun 10, 2024
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  3. May 24, 2024
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  4. Apr 24, 2024
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. Form 1-A amendments state no reason; those filed before qualification are usually responses to SEC staff review.

Deal terms

Est. pre-money$1.2M
Price / share$0.0125
Shares offered75,000,000

Estimated, not stated: $0.0125 × 97,899,861 securities outstanding.

Offering details

Target—
Max$937,500
Min investment—
OpenedApr 19, 2024
Deadline—
ClosedJun 24, 2024
Days active66

Links & provenance

Source: SEC EDGAR
0001683168-24-002519
Last synced Aug 16, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.